RCM
CVS icon

Raleigh Capital Management’s CVS Health CVS Stock Holding History

Raleigh Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.93K Sell
67
-168
-71% -$15K ﹤0.01% 390
2026
Q1 		$16.9K Buy
+235
New +$18.1K 0.01% 358
2025
Q2 		– Sell
-19
Closed -$1.29K – 654
2025
Q1 		$1.29K Sell
19
-92
-83% -$5.51K ﹤0.01% 440
2024
Q4 		$4.98K Sell
111
-160
-59% -$8.98K ﹤0.01% 711
2024
Q3 		$17K Sell
271
-92
-25% -$5.37K 0.01% 471
2024
Q2 		$21.4K Sell
363
-117
-24% -$7.32K 0.01% 420
2024
Q1 		$38.3K Buy
480
+235
+96% +$18K 0.02% 335
2023
Q4 		$19.3K Sell
245
-269
-52% -$19.1K 0.01% 451
2023
Q3 		$35.9K Buy
514
+79
+18% +$5.6K 0.02% 299
2023
Q2 		$30.1K Sell
435
-6,284
-94% -$447K 0.02% 310
2023
Q1 		$499K Sell
6,719
-2,246
-25% -$188K 0.25% 109
2022
Q4 		$835K Sell
8,965
-66
-0.7% -$6.37K 0.43% 67
2022
Q3 		$861K Buy
9,031
+425
+5% +$42.1K 0.5% 62
2022
Q2 		$803K Buy
8,606
+721
+9% +$70.4K 0.46% 66
2022
Q1 		$798K Buy
7,885
+7,820
+12,031% +$822K 0.43% 69
2021
Q4 		$7K Buy
+65
New +$6.01K 0.01% 214

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Raleigh Capital Management's CVS Position: Q2 2026 in Review

Raleigh Capital Management reduced its CVS Health (CVS) stake by 71% in Q2 2026, selling an estimated $15K and leaving 67 shares worth $6.93K. The position accounts for ﹤0.01% of the portfolio, ranked #390.

Raleigh Capital Management first reported a position in CVS in Q4 2021 and has held it in 16 quarters since. The position peaked at $861K in Q3 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Raleigh Capital Management held 67 shares of CVS Health worth $6.93K as of Q2 2026.
  • Raleigh Capital Management sold 168 CVS Health shares in Q2 2026, an estimated $15K.
  • CVS Health made up ﹤0.01% of Raleigh Capital Management's portfolio in Q2 2026, its #390 holding.
  • Raleigh Capital Management first reported a position in CVS Health in Q4 2021 and has held it in 16 quarters since.
  • Raleigh Capital Management's CVS Health position peaked at $861K in Q3 2022.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.